Antibacterial wound dressings activated with tuned nanocomposites through the electrophoretic deposition techniques

ShimyaTech(ST)开发了一项创新技术，将纳米膜附着在医疗用固体支撑物上，以对抗细菌生物膜和伤口感染日益增长的影响。据报道，由于各种事故(从道路到剖腹产手术等)的增加，对伤口护理敷料产品的需求将进一步扩大，这项创新将提供更安全、更具成本效益的新一代产品，将带来投资、经济增长和对公众健康及其成本的巨大好处。我们的技术建立在附着在固体表面上的可调纳米材料复合材料的应用之上，已被证明是用于包括伤口敷料在内的医疗设备涂层的强大功能。这将是防止感染传播的重要一步，感染传播每年给NHS带来高达10亿英镑的主要成本。我们已经克服了应用纳米颗粒的关键挑战，包括防止纳米颗粒逃逸和释放到环境中，这可能会对患者的健康产生不利影响。在这个项目中，我们旨在展示我们开发的技术应用于伤口敷料产品的有效性和可扩展性，以及我们如何将其推向市场。需要快速采取一些关键步骤，为该技术商业化和推向市场做好准备。我们将通过组建一个强大的财团来推进该项目，以领导该技术的规模扩大，并在伤口敷料制造公司推出工业应用。将对该技术和原型伤口敷料商业化的市场需求和法规进行研究。公共意识和教育内容将作为该项目的成果进行制作和传播。

ShimyaTech (ST) has developed an innovative technology for the attachment of nanofilms on solid supports for medical usage to combat the growing impact of bacterial biofilms and wound infections. With the reported sharp increases in the demand for wound care dressing products, anticipated to further extend due to the increased figures of varied incidents (from road to caesarean procedures, etc.), the innovation will offer a new generation of safer and more cost-efficient products which will induce investment, economic growth and vast benefits to public health and its costs.Our technology, built on the application of tuned nanomaterial composites attached to solid surfaces, has proven strong features to use as coating on medical devices including wound dressings. This will be a major step in prevention of the spread of infection, which incurs major costs to NHS up to £1bn per year. We have overcome key challenges in applying nanoparticles including prevention of the escape of nanoparticles and their release to the environment, which can have a detrimental effect on patient health.In this project, we aim to demonstrate the efficacy and scalability of our developed technology application in wound dressing products, and also how we can take it to markets. Some critical steps are required to take at a fast pace to prepare the technology for commercialisation and introduction to markets. We will pursue the project by forming a strong consortium to lead the scaling up of the technology and launch industrial application at wound dressing manufacturing firms. Study of market requirements and regulations for commercialisation of the technology and the prototyped wound dressings will be investigated. Public awareness and educational contents will be produced and disseminated as outcomes from the project.